Director sells 14,205 shares; TWST reporting person lists multiple disposals (TWST)
Rhea-AI Filing Summary
Twist Bioscience-related reporting person reported sales of Common Stock in multiple transactions. The largest single sale listed was 14,205 shares for $990,798.75 on 05/29/2026, with additional sales of 1,962 shares ($112,125.95), 1,642 shares ($87,447.34), 402 shares ($28,077.37), and 346 shares ($30,213.55) on the dates shown.
Positive
- None.
Negative
- None.
Insights
Multiple open-market dispositions by a reporting person are disclosed.
The filing lists five separate Common Stock sales by the reporting person, the largest being 14,205 shares for $990,798.75 on 05/29/2026. The transactions are itemized with share counts and gross proceeds.
These entries are routine disclosure of insider dispositions under resale rules; cash‑flow treatment is the proceeds to the selling holder and timing is per the listed trade dates.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Vesting financial
proceeds financial
Issuer regulatory
FAQ
What did the Form 144 for TWST report?
Do these Form 144 entries show restricted stock vesting activity?
Are the trades listed on specific dates in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.